CIPH Ciphergen Biosystems (MM)

FREMONT, Calif., March 2 /PRNewswire-FirstCall/ -- Ciphergen (NASDAQ:CIPH) announced today that it will webcast its presentation at the SG Cowen 26th Annual Health Care Conference in Boston. Gail Page, President & CEO, will provide a company overview at 8:50 a.m. EST on Tuesday, March 7, 2006. A webcast of the presentation will be available live and by replay. To access both the live and archived webcast, please go to http://www.ciphergen.com/ and click on the "Investors" link. The archived replay will be available for 24 hours after the live presentation and will be accessible for 30 days. About Ciphergen Ciphergen is dedicated to the discovery of protein biomarkers and panels of biomarkers and their development into protein molecular diagnostic tests that improve patient care; and to providing collaborative R&D services through its Biomarker Discovery Center(R) laboratories for biomarker discovery for new diagnostic tests as well as pharmacoproteomic services for improved drug toxicology, efficacy and theranostic assays. Ciphergen develops, manufactures and markets a family of ProteinChip(R) Systems and services for clinical, research and process proteomics applications. ProteinChip Systems enable protein discovery, validation, identification and assay development to provide researchers with predictive, multi-marker assay capabilities and a better understanding of biological function at the protein level. Additional information about Ciphergen can be found at http://www.ciphergen.com/. NOTE: Ciphergen, ProteinChip, and Biomarker Discovery Center are registered trademarks of Ciphergen Biosystems, Inc. DATASOURCE: Ciphergen Biosystems, Inc. CONTACT: Sue Carruthers, Investor Relations of Ciphergen Biosystems, Inc., +1-510-505-2297 Web site: http://www.ciphergen.com/

Copyright